Cover Image

Prevalence of carbapenemase producing Enterobacterales colonization and risk factor of clinical infection

Background: Carbapenemase-producing Enterobacterales (CPE) are global concerns in infection control, and the number of CPE outbreaks in hospitals is increasing despite the strengthening of contact precautions. This study aimed to confirm the prevalence and transition rate of CPE infection from stool...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kyoung Hwa Lee (Author), Dokyun Kim (Author), Jun Sung Hong (Author), Soon Young Park (Author), Nan Hyoung Cho (Author), Mi Na Kim (Author), Yun Jung Lee (Author), Yeonji Wi (Author), Eun Hwa Lee (Author), Sang Hoon Han (Author), Seok Hoon Jeong (Author), Young Goo Song (Author)
Format:	Book
Published:	Elsevier, 2023-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Risk Factors for Carbapenemase-Producing <i>Enterobacterales</i> Infection or Colonization in a Korean Intensive Care Unit: A Case-Control Study
by: Young Ah Kim, et al.
Published: (2020)

Carbapenemase-Producing Enterobacterales
Published: (2022)

Risk Factors and Outcomes of Patients Colonized with KPC and NDM Carbapenemase-Producing Enterobacterales
by: Lisa Saidel-Odes, et al.
Published: (2024)

Evaluation of the BD Phoenix CPO Detect Panel for Detection and Classification of Carbapenemase Producing <i>Enterobacterales</i>
by: Harshad Lade, et al.
Published: (2023)

Paradoxical consequences of wastewater interventions targeting carbapenemase-producing Enterobacterales
by: David Lehman, et al.
Published: (2023)

The Importance of Carbapenemase-Producing Enterobacterales in African Countries: Evolution and Current Burden
by: Edgar-Costin Chelaru, et al.
Published: (2024)

Novel Mutations Conferring Amoxicillin Resistance in <i>Helicobacter pylori</i> in South Korea
by: Soon Young Park, et al.
Published: (2023)

Molecular epidemiology characteristics and detecting transmission of carbapenemase-producing enterobacterales in southwestern China
by: Jin Deng, et al.
Published: (2022)

Prevalence and Molecular Typing of Carbapenemase-Producing Enterobacterales among Newborn Patients in Italy
by: Marilena Agosta, et al.
Published: (2022)

Determining the impact of professional body recommendations on the screening of acquired carbapenemase-producing Enterobacterales in England
by: Kirsty F. Bennet, et al.
Published: (2023)

Multicenter Study of Carbapenemase-Producing <i>Enterobacterales</i> in Havana, Cuba, 2016-2021
by: Haiyang Yu, et al.
Published: (2022)

Comparative Meropenem Pharmacodynamics and Emergence of Resistance against Carbapenem-Susceptible Non-Carbapenemase-Producing and Carbapenemase-Producing Enterobacterales: A Pharmacodynamic Study in a Hollow-Fiber Infection Model
by: Maria V. Golikova, et al.
Published: (2023)

Whole Genome Sequencing to Identify Multiple Clusters of Carbapenemase-Producing Enterobacterales Cases - Colorado, 2022-2023
by: Jennifer Driscoll, et al.
Published: (2024)

Long time persistence and evolution of carbapenemase-producing Enterobacterales in the wastewater of a tertiary care hospital in Germany
by: Laura Carlsen, et al.
Published: (2023)

The emergence of carbapenemase-producing Enterobacterales in hospitals: a major challenge for a debilitated healthcare system in Lebanon
by: Dina Daaboul, et al.
Published: (2023)

Fecal Carriage and Epidemiology of Extended-Spectrum Beta-Lactamase/Carbapenemases Producing Enterobacterales Isolates in Bulgarian Hospitals
by: Rumyana Markovska, et al.
Published: (2021)

Epidemiological Characteristics of Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae Colonization
by: Ihn Sook Jeong, et al.
Published: (2022)

Epidemiology and Risk Factors of Carbapenemase-Producing <em>Enterobacteriaceae</em> Acquisition and Colonization at a Korean Hospital over 1 Year
by: Hye-Jin Kim, et al.
Published: (2023)

Clinical, microbiological characteristics and predictors of mortality in patients with carbapenemase-producing Enterobacterales bloodstream infections: a multicentre study
by: Vanesa Anton-Vazquez, et al.
Published: (2023)

Mortality rates among non-Hispanic Black and White persons in carbapenemase-producing Enterobacterales, Tennessee, 2015-2019
by: Erika Kirtz, et al.
Published: (2022)

Emergence of carbapenemase-producing Enterobacterales (CPE) in patients with severe COVID-19 infection and successful control in intensive care
by: Anthony Longhitano, et al.
Published: (2024)

Genomic and epidemiological insight of an outbreak of carbapenemase-producing Enterobacterales in a Portuguese hospital with the emergence of the new KPC-124
by: Vera Manageiro, et al.
Published: (2024)

OXA-48 Carbapenemase-Producing Enterobacterales in Spanish Hospitals: An Updated Comprehensive Review on a Rising Antimicrobial Resistance
by: Mario Rivera-Izquierdo, et al.
Published: (2021)

Social network and genomic analysis of an OXA-48 carbapenemase-producing Enterobacterales hospital ward outbreak in Ireland, 2018-2019
by: Lisa Domegan, et al.
Published: (2023)

Response to Author Comments on "Clinical, microbiological characteristics and predictors of mortality in patients with carbapenemase-producing Enterobacterales blood stream infections"
by: Vanesa Anton-Vazquez, et al.
Published: (2023)

Carbapenemase producing Enterobacterales at a large teaching hospital in Ohio: comparison to state surveillance and retrospective analysis of patient characteristics
by: Amanda Carroll, et al.
Published: (2024)

Knowledge, attitudes and self-reported practices of healthcare professionals on Carbapenemase Producing Enterobacterales (CPE): A cross sectional study
by: Shaini Paul Mathew, et al.
Published: (2023)

In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing Enterobacterales
by: Rémy A. Bonnin, et al.
Published: (2023)

Efficacy and Gut Dysbiosis of Gentamicin-Intercalated Smectite as a New Therapeutic Agent against <em>Helicobacter pylori </em>in a Mouse Model
by: Su Jin Jeong, et al.
Published: (2020)

Carbapenemase-producing Eenterobacterales from hospital environment and their relation to those from patient specimens
by: Si Hyun Kim, et al.
Published: (2022)

Follow up to 'Clinical, microbiological characteristics and predictors of mortality in patients with carbapenemase producing Enterobacterales bloodstream infections: a multicentre study'
by: Manjula Meda, et al.
Published: (2023)

Outbreak of New Delhi Metallo-Beta-lactamase Carbapenemase Producing Enterobacterales on a bone marrow transplant unit: Role of the environment
by: Katherine Prescott, et al.
Published: (2021)

Clinical and Demographic Characteristics of Patients With a New Diagnosis of Carriage or Clinical Infection With Carbapenemase-Producing Enterobacterales: A Retrospective Study
by: Assaf Adar, et al.
Published: (2021)

In vitro pharmacokinetics/pharmacodynamics of FL058 (a novel beta-lactamase inhibitor) combined with meropenem against carbapenemase-producing Enterobacterales
by: Zhiwei Huang, et al.
Published: (2024)

Evaluation of the Performances of the Rapid Test RESIST-5 O.O.K.N.V Used for the Detection of Carbapenemases-Producing Enterobacterales
by: Assiya El Kettani, et al.
Published: (2021)

Comparison of Six Phenotypic Assays with Reference Methods for Assessing Colistin Resistance in Clinical Isolates of Carbapenemase-Producing Enterobacterales: Challenges and Opportunities
by: Annamária Főldes, et al.
Published: (2022)

Risk factors associated with colistin resistance in carbapenemase-producing Enterobacterales: a multicenter study from a low-income country
by: Soria-Segarra Claudia, et al.
Published: (2023)

Detection of Multidrug-Resistant <i>Enterobacterales</i>-From ESBLs to Carbapenemases
by: Janina Noster, et al.
Published: (2021)

Risk factors of carbapenemase-producing Enterobacterales acquisition among adult intensive care unit patients at a Kentucky Academic Medical Center
by: Jason Eric Wilson, et al.
Published: (2023)

Microbial epidemiology and clinical risk factors of carbapenemase-producing Enterobacterales amongst Irish patients from first detection in 2009 until 2020
by: N.H. O'Connell, et al.
Published: (2022)